Page last updated: 2024-08-23

daunorubicin and Colonic Neoplasms

daunorubicin has been researched along with Colonic Neoplasms in 57 studies

Research

Studies (57)

Timeframe	Studies, this research(%)	All Research%
pre-1990	19 (33.33)	18.7374
1990's	18 (31.58)	18.2507
2000's	13 (22.81)	29.6817
2010's	6 (10.53)	24.3611
2020's	1 (1.75)	2.80

Authors

Authors	Studies
Berscheid, HG; Böttger, D; Hermentin, P; Hoffmann, D; Kraemer, HP; Sedlacek, HH	1
Biri-Kovács, B; Enyedi, KN; Kapuvári, B; Kiss, K; Mező, G; Orosz, Á; Ranđelović, I; Schlosser, G; Szabó, R; Tóvári, J	1
Hegedüs, R; Kőhidai, L; Lajkó, E; Mező, G	1
Chavez-Blanco, A; Diaz-Chavez, J; Dominguez-Gomez, G; Duenas-Gonzalez, A; Hua, S; Juarez, M; Lai, D; Perez-Montiel, D; Ponce-Toledo, RI; Schcolnik-Cabrera, A; Torres, N; Tovar, AR; Vargas-Castillo, A	1
Bazylińska, U; Chodaczek, G; Gamian, A; Pietkiewicz, J; Rossowska, J; Wilk, KA	1
Altman, J; Kuzel, T; Parajuli, R; Perdekamp, M; Tallman, M	1
Bosze, S; Manea, M; Mezo, G; Orbán, E; Schlage, P	1
Kapuvári, B; Manea, M; Mezo, G; Schulcz, A; Tejeda, M; Tóvári, J; Vincze, B	1
Barbu, V; Bentires-Alj, M; Bours, V; Chariot, A; Fillet, M; Gielen, J; Jacobs, N; Merville, MP; Relic, B	1
Balázs, B; Falus, A; Hudecz, F; Reményi, J; Tóth, G; Tóth, S	1
Aizawa, K; Hatsugai, Y; Inakuma, T; Konishi, T; Nagasawa, H; Nagata, S; Sakuda, SH; Satsu, H; Shimizu, M	2
Abdul-Ghani, R; Dietel, M; Garber, M; Györffy, B; Jürchott, K; Lage, H; Petersen, I; Schäfer, R; Serra, V; Stein, U	1
Cao, X; Chen, W; Sun, D; Wang, PG; Zhang, G; Zhu, L	1
Boyd, DD; Fokt, I; Jamaluddin, MS; Nair, RR; Priebe, W; Wang, H	1
Chapelle, JP; Chariot, A; Close, P; Cornez, I; Creppe, C; Dejardin, E; Gillard, M; Hennuy, B; Merville, MP	1
Glazer, RI; Johnston, JB	2
Delorme, F; Dumas, L; Lafontaine, F; Pagé, M	1
Fuks, A; Guidoni, L; O'Hara, CJ; Price, GB; Shuster, J	1
Arita, N; Kajiwara, S; Kono, H; Ohmori, T; Tabei, R	1
Ahmed, T; Arena, F; Cheng, E; Faye, L; Harper, HD; Kemeny, NE; Sordillo, P	1
Glazer, RI; Johnston, JB; Kerrigan, D; Lloyd, LS; Zwelling, LA	1
Bruno, S; Weiss, RB	1
Glazer, RI; Hartman, KD; Richardson, CL	1
Belles-Isles, M; Pagé, M	1
Baccarani, M; Candoni, A; Damiani, D; Marie, JP; Melli, C; Michelutti, A; Michieli, MG; Russo, D; Zhou, DC; Zittoun, R	1
De Bruijn, EA; Eggermont, A; Gheuens, E; Van Bockstaele, D; van de Vrie, W; van der Heyden, S; Van Oosterom, A	1
Burris, HA; Campbell, E; Cobb, P; Eckardt, JR; Fields, SM; Peacock, NW; Rodriguez, GI; Rothenberg, ML; Thurman, AM; Weiss, GR	1
Boiocchi, M; Gigante, M; Simone, F; Toffoli, G	1
Baccarani, M; Damiani, D; Lauria, F; Michelutti, A; Michieli, M; Pipan, C; Raspadori, D	1
Baccarani, M; Cerno, M; Damiani, D; Melli, C; Michelutti, A; Michieli, M	1
Fernández Puentes, JL; García Grávalos, MD; Quesada, AR	1
Alvord, WG; Gazdar, AF; Gray-Goodrich, M; Koo, HM; McWilliams, MJ; Mikheev, A; Monks, A; Oie, HK; Paull, KD; Rubinstein, LV; Vande Woude, GF; Zarbl, H	1
Bours, V; Calmant, P; Gielen, J; Hellin, AC; Merville, MP	1
Alvord, WG; Gray-Goodrich, M; Jeffers, M; Kohlhagen, G; Koo, HM; McWilliams, MJ; Monks, A; Paull, KD; Pommier, Y; Vaigro-Wolff, A; Vande Woude, GF	1
Cadenas, E; Mueller, S; Schönthal, AH	1
Fernandez, H; Hu, YP; Krishan, A; Lyubimov, E; Mou, C; Sridhar, KS; Stein, WD	1
Colosetti, P; Finance, C; Marchal, S; Merlin, JL	1
Benoit, V; Bours, V; Gielen, J; Hellin, AC; Huygen, S; Merville, MP	1
Hellström, I; Hellström, KE; Senter, PD	1
Chauvier, D; Manfait, M; Morjani, H	1
Baker, LH; Buroker, TR; Fraile, RJ; O'Bryan, R; Samson, MK; Vaitkevicius, VK	1
Carey, RW; Kardinal, CG; Kennedy, BJ; Perry, MC; Weiss, RB; White, LA	1
Adler, R; Hurwitz, E; Sela, M; Shouval, D; Takahashi, H; Wands, JR	1
Broxterman, HJ; Dekker, H; Lankelma, J; Schuurhuis, GJ; Spoelstra, EC	1
Ascari, E; Danova, M; Giordano, M; Invernizzi, R; Luoni, R; Rastaldi, MP; Riccardi, A; Ucci, G; Zambelli, ML	1
Diatchkovskaya, RF; Ganieva, LKh; Konovalova, NP; Lapshin, IM; Shapiro, AB; Volkova, LM	1
Goldenberg, DM; Hall, TC; Lu, H; Sharkey, RM; Shih, LB; Xuan, H	1
Matsuo, K; Sugimoto, Y; Takeda, S; Tsukagoshi, S; Yamada, Y	1
Belvedere, G; D'Incalci, M; Geroni, C; Giuliani, FC; Suarato, A	1
Barrett, J; Benson, AB; Blough, R; Chernicoff, D; Hoeltgen, T; Johnson, C; Kilton, L; Knop, RH; Locker, GY	1
Begleiter, A; Johnston, JB; Pugh, L	1
Armitage, NC; Baldwin, RW; Ballantyne, KC; Durrant, LG; Gallego, J; Garnett, MC; Hardcastle, JD; Marksman, RA	1
Geroni, C; Giuliani, FC; Grandi, M	1
Begleiter, A; Glazer, RI; Johnston, JB	1
Bonnem, E; Goodman, A; Grady, K; Harvey, J; Schein, P	1

Reviews

2 review(s) available for daunorubicin and Colonic Neoplasms

Article

Year

Daunorubicin treatment of adult solid tumors.

Cancer treatment reports, 1981, Volume: 65 Suppl 4

Topics: Adult; Clinical Trials as Topic; Colonic Neoplasms; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Lymphoma; Male; Neoplasms; Sarcoma; Urinary Bladder Neoplasms

1981

Development and activities of the BR96-doxorubicin immunoconjugate.

Methods in molecular biology (Clifton, N.J.), 2001, Volume: 166

Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antigens, Neoplasm; Carcinoma; Clinical Trials, Phase I as Topic; Colonic Neoplasms; Daunorubicin; Digestive System; Doxorubicin; Drug Design; Gastrointestinal Diseases; Humans; Immunotoxins; Lewis Blood Group Antigens; Mice; Mice, Nude; Neoplasms; Neoplasms, Experimental; Organ Specificity; Rats; Rats, Inbred BN; Rats, Nude; Treatment Failure; Xenograft Model Antitumor Assays

2001

Trials

4 trial(s) available for daunorubicin and Colonic Neoplasms

Article	Year
Daunorubicin treatment of adult solid tumors. Cancer treatment reports, 1981, Volume: 65 Suppl 4 Topics: Adult; Clinical Trials as Topic; Colonic Neoplasms; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Lymphoma; Male; Neoplasms; Sarcoma; Urinary Bladder Neoplasms	1981
A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colon. American journal of clinical oncology, 1994, Volume: 17, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Daunorubicin; Drug Carriers; Female; Humans; Liposomes; Male; Middle Aged; Remission Induction	1994
Synergistic effect of prochlorperazine and dipyridamole on the cellular retention and cytotoxicity of doxorubicin. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:4 Topics: Animals; Antineoplastic Agents; Area Under Curve; Cell Survival; Colonic Neoplasms; Culture Media; Daunorubicin; Dipyridamole; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Neoplasms; Plasma; Prochlorperazine; Tumor Cells, Cultured	2000
Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine. Cancer treatment reports, 1978, Volume: 62, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Colonic Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Rectal Neoplasms	1978

Other Studies

52 other study(ies) available for daunorubicin and Colonic Neoplasms

Article	Year
Structure-activity relationship of anthracyclines in vitro. Journal of medicinal chemistry, 1990, Volume: 33, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry, Physical; Colonic Neoplasms; DNA; Humans; Leukemia L1210; Molecular Structure; Neoplasms; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured	1990
Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems. European journal of medicinal chemistry, 2019, Aug-15, Volume: 176 Topics: Animals; Antineoplastic Agents; Cathepsin B; Cell Proliferation; Cell Surface Display Techniques; Colonic Neoplasms; Daunorubicin; Drug Delivery Systems; Drug Liberation; Female; HT29 Cells; Humans; Mice, SCID; Oligopeptides; Prodrugs; Proteolysis; Rats; Xenograft Model Antitumor Assays	2019
Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells. International journal of molecular sciences, 2019, Sep-08, Volume: 20, Issue:18 Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Computational Biology; Daunorubicin; Dose-Response Relationship, Drug; Gene Expression Profiling; Gonadotropin-Releasing Hormone; Humans; Transcriptome	2019
Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy. Scientific reports, 2021, 03-04, Volume: 11, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Daunorubicin; Energy Metabolism; Gene Expression Regulation, Neoplastic; Glycolysis; Growth Hormone; Humans; Indazoles; Indomethacin; Insulin; Metabolic Networks and Pathways; Metabolism; Mice; Mitoxantrone; Orlistat; Oxidative Phosphorylation; Vincristine	2021
Polyelectrolyte Oil-Core Nanocarriers for Localized and Sustained Delivery of Daunorubicin to Colon Carcinoma MC38 Cells: The Case of Polysaccharide Multilayer Film in Relation to PEG-ylated Shell. Macromolecular bioscience, 2017, Volume: 17, Issue:5 Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Biocompatible Materials; Cell Line; Cell Line, Tumor; Colonic Neoplasms; Daunorubicin; Drug Carriers; Erythrocytes; Hemolysis; Mice; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Nanoparticles; Polyelectrolytes; Polyethylene Glycols; Polysaccharides	2017
Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association? American journal of hematology, 2010, Volume: 85, Issue:10 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colonic Neoplasms; Colonic Polyps; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Idarubicin; Indoles; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasms, Second Primary; Pyrroles; Remission Induction; Sunitinib; Time Factors; Tretinoin	2010
Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect. Journal of controlled release : official journal of the Controlled Release Society, 2011, Dec-10, Volume: 156, Issue:2 Topics: Amino Acid Sequence; Antibiotics, Antineoplastic; Breast Neoplasms; Cathepsin B; Cell Line, Tumor; Colonic Neoplasms; Daunorubicin; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Humans; Lysosomes	2011
In-vivo antitumour effect of daunorubicin-GnRH-III derivative conjugates on colon carcinoma-bearing mice. Anti-cancer drugs, 2012, Volume: 23, Issue:1 Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Daunorubicin; Dose-Response Relationship, Drug; Female; Gonadotropin-Releasing Hormone; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mice, SCID; Pyrrolidonecarboxylic Acid; Xenograft Model Antitumor Assays	2012
NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene, 2003, Jan-09, Volume: 22, Issue:1 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Colonic Neoplasms; Daunorubicin; DNA Primers; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Neoplastic; Humans; Introns; NF-kappa B; Plasmids; Promoter Regions, Genetic; Transcriptional Activation; Tumor Cells, Cultured	2003
Isomer-dependent daunomycin release and in vitro antitumour effect of cis-aconityl-daunomycin. Biochemical and biophysical research communications, 2003, Apr-04, Volume: 303, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Colonic Neoplasms; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Indicators and Reagents; Isomerism; Kinetics; Magnetic Resonance Spectroscopy; Tumor Cells, Cultured	2003
Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells. British journal of pharmacology, 2004, Volume: 143, Issue:3 Topics: Adenocarcinoma; Amino Acids; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Caco-2 Cells; Chromatography, High Pressure Liquid; Colonic Neoplasms; Daunorubicin; Dose-Response Relationship, Drug; Fruit; Glycerides; Hot Temperature; Humans; L-Lactate Dehydrogenase; Mass Spectrometry; Methanol; Momordica charantia; Plant Extracts; Pronase; Rhodamine 123; Vegetables	2004
A bitter melon extract inhibits the P-glycoprotein activity in intestinal Caco-2 cells: monoglyceride as an active compound. BioFactors (Oxford, England), 2004, Volume: 22, Issue:1-4 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Chromatography, High Pressure Liquid; Colonic Neoplasms; Cucurbitaceae; Daunorubicin; Glycerides; Humans; Palmitic Acid; Phytotherapy; Plant Extracts	2004
Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival. Oncogene, 2005, Nov-17, Volume: 24, Issue:51 Topics: Algorithms; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Female; Forecasting; Gene Expression Profiling; Humans; Mitoxantrone; Oligonucleotide Array Sequence Analysis; Predictive Value of Tests; Prognosis; Stomach Neoplasms; Survival Analysis	2005
Syntheses and biological activities of daunorubicin analogs with uncommon sugars. Bioorganic & medicinal chemistry, 2005, Dec-01, Volume: 13, Issue:23 Topics: Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Daunorubicin; Humans; Inhibitory Concentration 50; Molecular Structure	2005
A bisanthracycline (WP631) represses uPAR gene expression and cell migration of RKO colon cancer cells by interfering with transcription factor binding to a chromatin-accessible -148/-124 promoter region. Oncology research, 2005, Volume: 15, Issue:5 Topics: Antibiotics, Antineoplastic; Binding, Competitive; Cell Line, Tumor; Cell Movement; Chromatin; Colonic Neoplasms; Daunorubicin; Gene Expression Regulation, Neoplastic; Humans; Promoter Regions, Genetic; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Sp1 Transcription Factor; Transcription Factors; Transcription, Genetic	2005
Deregulated expression of pro-survival and pro-apoptotic p53-dependent genes upon Elongator deficiency in colon cancer cells. Biochemical pharmacology, 2008, Jun-01, Volume: 75, Issue:11 Topics: Antineoplastic Agents; Apoptosis; Carrier Proteins; Cell Line, Tumor; Colonic Neoplasms; Daunorubicin; DNA Damage; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Immediate-Early Proteins; Intracellular Signaling Peptides and Proteins; Multiprotein Complexes; Protein Serine-Threonine Kinases; RNA Interference; RNA, Messenger; Transcriptional Elongation Factors; Tumor Suppressor Protein p53	2008
Pharmacological studies of 3'-(4-morpholinyl)-3'-deaminodaunorubicin in human colon carcinoma cells in vitro. Cancer research, 1983, Volume: 43, Issue:3 Topics: Adenocarcinoma; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Daunorubicin; DNA Replication; Doxorubicin; Humans; In Vitro Techniques; RNA; Time Factors	1983
Chemotherapy with daunorubicin-anti-CEA conjugates in human colon adenocarcinoma grafted in nude mice. Seminars in oncology, 1984, Volume: 11, Issue:4 Suppl 3 Topics: Adenocarcinoma; Animals; Antibodies, Neoplasm; Carcinoembryonic Antigen; Colonic Neoplasms; Daunorubicin; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous	1984
Targeting of liposomes: monoclonal antibodies coupled to phospholipid vesicles provide selective transfer of trapped reagents into cultured cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 1984, Volume: 5, Issue:1 Topics: Animals; Antibodies, Monoclonal; Carcinoembryonic Antigen; Cell Line; Cell Survival; Centrifugation, Density Gradient; Colonic Neoplasms; Cricetinae; Cricetulus; Daunorubicin; Drug Resistance; Female; Humans; Immunoglobulin G; Liposomes; Microscopy, Electron; Ovary; Sonication	1984
Primary colonic plasmacytoma associated with acute myelogenous leukemia. The American journal of gastroenterology, 1984, Volume: 79, Issue:4 Topics: Adult; Colon; Colonic Neoplasms; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Plasmacytoma; Prednisolone	1984
Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma. Cancer treatment reports, 1984, Volume: 68, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Male; Middle Aged; Rectal Neoplasms	1984
Cellular pharmacology of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin in human colon carcinoma cells in vitro. Cancer research, 1983, Volume: 43, Issue:4 Topics: Cell Line; Cell Nucleus; Cell Survival; Colonic Neoplasms; Daunorubicin; DNA Replication; Humans; Kinetics; Structure-Activity Relationship; Transcription, Genetic	1983
Comparison of DNA scission and cytotoxicity produced by Adriamycin and 5-iminodaunorubicin in human colon carcinoma cells. Biochemical pharmacology, 1983, Jul-15, Volume: 32, Issue:14 Topics: Cell Survival; Cells, Cultured; Colonic Neoplasms; Daunorubicin; DNA; DNA Repair; DNA, Single-Stranded; Dose-Response Relationship, Drug; Doxorubicin; Humans; Kinetics	1983
Cytokinetic and biochemical effects of 5-iminodaunorubicin in human colon carcinoma in culture. Cancer research, 1982, Volume: 42, Issue:1 Topics: Cell Survival; Cells, Cultured; Colonic Neoplasms; Daunorubicin; DNA, Neoplasm; Doxorubicin; Humans; Molecular Weight; Neoplasms, Experimental; RNA, Neoplasm	1982
Anti-oncofoetal proteins for targeting cytotoxic drugs. International journal of immunopharmacology, 1981, Volume: 3, Issue:1 Topics: Antibodies; Antineoplastic Agents; Carcinoembryonic Antigen; Cells, Cultured; Colonic Neoplasms; Daunorubicin; Humans; Neoplasms, Experimental; Stimulation, Chemical; Uridine	1981
MDR-related P170-glycoprotein modulates cytotoxic activity of homoharringtonine. Leukemia, 1995, Volume: 9, Issue:3 Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Colonic Neoplasms; Cyclosporins; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Gene Amplification; Harringtonines; Homoharringtonine; Humans; Leukemia-Lymphoma, Adult T-Cell; Neoplasm Proteins; Tumor Cells, Cultured; Verapamil; Vinblastine	1995
5'-Deoxy-5-fluorouridine increases daunorubicin uptake in multidrug-resistant cells and its activity is related with P-gp 170 expression. Japanese journal of cancer research : Gann, 1994, Volume: 85, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Carrier Proteins; Colonic Neoplasms; Daunorubicin; Drug Resistance; Flow Cytometry; Floxuridine; Membrane Glycoproteins; Prodrugs; Rats; Tumor Cells, Cultured	1994
Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines. Biochemical pharmacology, 1994, Nov-16, Volume: 48, Issue:10 Topics: Affinity Labels; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biological Transport; Cell Membrane; Cell Nucleus; Clone Cells; Colonic Neoplasms; Daunorubicin; Dihydropyridines; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Fluorescence; Humans; Idarubicin; Tumor Cells, Cultured	1994
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives. Leukemia & lymphoma, 1993, Volume: 9, Issue:3 Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Colonic Neoplasms; Daunorubicin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Gene Expression; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Tumor Cells, Cultured	1993
D-verapamil downmodulates P170-associated resistance to doxorubicin, daunorubicin and idarubicin. Anti-cancer drugs, 1993, Volume: 4, Issue:2 Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Survival; Colonic Neoplasms; Daunorubicin; Doxorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Tumor Cells, Cultured; Verapamil	1993
Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein. British journal of cancer, 1996, Volume: 74, Issue:5 Topics: Adenocarcinoma; Alkaloids; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Colonic Neoplasms; Cricetinae; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia P388; Lung Neoplasms; Mice; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Verapamil; Vinblastine	1996
Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes. Cancer research, 1996, Nov-15, Volume: 56, Issue:22 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Cytarabine; Daunorubicin; Deoxycytidine; DNA Mutational Analysis; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gemcitabine; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Lung Neoplasms; Software; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1996
Nuclear factor - kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug. Oncogene, 1998, Mar-05, Volume: 16, Issue:9 Topics: Antibiotics, Antineoplastic; Cell Nucleus; Chloramphenicol O-Acetyltransferase; Colonic Neoplasms; Daunorubicin; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Luciferases; NF-kappa B; Promoter Regions, Genetic; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53	1998
The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis. Journal of the National Cancer Institute, 1999, Feb-03, Volume: 91, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Carbazoles; Colonic Neoplasms; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Genes, ras; Humans; Mutation; Phenotype; Pyridines; Topoisomerase II Inhibitors; Transfection; Tumor Cells, Cultured	1999
p21WAF1 regulates anchorage-independent growth of HCT116 colon carcinoma cells via E-cadherin expression. Cancer research, 2000, Jan-01, Volume: 60, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Antibodies; Apoptosis; Cadherins; Cell Adhesion; Cell Communication; Cell Division; Cell Survival; Cell Transformation, Neoplastic; Chick Embryo; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; Humans; In Situ Nick-End Labeling; Neoplasm Proteins; Oligonucleotides, Antisense; Phenotype; Transfection; Tumor Cells, Cultured	2000
Influence of the fluoroquinolone ofloxacin on the intrinsic expression of multidrug resistance phenotype in HCT-8 human colon carcinoma cells. Oncology research, 1999, Volume: 11, Issue:8 Topics: Adenocarcinoma; Anti-Bacterial Agents; Anti-Infective Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Colonic Neoplasms; Daunorubicin; DNA Topoisomerases, Type I; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; Multidrug Resistance-Associated Proteins; Ofloxacin; Penicillins; Streptomycin; Tumor Cells, Cultured	1999
Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter. Oncogene, 2000, Sep-28, Volume: 19, Issue:41 Topics: Adenocarcinoma; Binding Sites; Colonic Neoplasms; Daunorubicin; DNA Damage; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, p53; Genes, Reporter; Genes, Synthetic; Humans; Models, Genetic; Neoplasm Proteins; NF-kappa B; Promoter Regions, Genetic; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; Transcriptional Activation; Tumor Suppressor Protein p53	2000
Homocamptothecin-daunorubicin association overcomes multidrug-resistance in breast cancer MCF7 cells. Breast cancer research and treatment, 2002, Volume: 73, Issue:2 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carcinoma; Colonic Neoplasms; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Leukemia, Myeloid; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Polymerase Chain Reaction; RNA, Neoplasm; Treatment Outcome; Tumor Cells, Cultured	2002
Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study. Cancer treatment reports, 1979, Volume: 63, Issue:2 Topics: Adenocarcinoma; Colonic Neoplasms; Daunorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Nitrosourea Compounds; Rectal Neoplasms; Semustine	1979
Immunotargeting of daunomycin to localized and metastatic human colon adenocarcinoma in athymic mice. Cancer immunology, immunotherapy : CII, 1992, Volume: 35, Issue:3 Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Colonic Neoplasms; Daunorubicin; Humans; Immunotoxins; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Transplantation, Heterologous	1992
P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport. Biochemical pharmacology, 1991, Feb-01, Volume: 41, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport, Active; Cell Survival; Colonic Neoplasms; Daunorubicin; Drug Resistance; Female; Glycerol; Humans; Membrane Glycoproteins; Mice; Neoplasm Proteins; Ovarian Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Verapamil	1991
[p170 in multiple myeloma and acute leukemia]. Haematologica, 1991, Volume: 76 Suppl 3 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Colonic Neoplasms; Cytarabine; Daunorubicin; Drug Resistance; Female; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Male; Melphalan; Membrane Glycoproteins; Middle Aged; Multiple Myeloma; Neoplasm Proteins; Neoplastic Stem Cells; Peptichemio; Plasma Cells; Prednisone; Remission Induction; Survival Rate; Tumor Cells, Cultured; Vincristine	1991
Subrenal capsule assay of human tumor chemosensitivity. Neoplasma, 1991, Volume: 38, Issue:3 Topics: Aclarubicin; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Evaluation Studies as Topic; Fluorouracil; Humans; Mice; Neoplasm Transplantation; Subrenal Capsule Assay	1991
Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrier. Cancer research, 1991, Aug-15, Volume: 51, Issue:16 Topics: Animals; Antibodies, Monoclonal; Carcinoembryonic Antigen; Cell Line; Cell Survival; Colonic Neoplasms; Daunorubicin; Doxorubicin; Drug Carriers; Drug Stability; Humans; Immunotoxins; Indicators and Reagents; Mice; Mice, Nude; Neoplasm Transplantation; Tissue Distribution; Transplantation, Heterologous; Tritium	1991
[Antitumor activities of orally administered 7-con-0-methylnogarol (TUT-7)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:3 Pt 1 Topics: Administration, Oral; Animals; Antineoplastic Agents; Colonic Neoplasms; Daunorubicin; Doxorubicin; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Menogaril; Mice; Nogalamycin; Rats; Sarcoma, Yoshida	1990
Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo). Biochemical pharmacology, 1989, Nov-01, Volume: 38, Issue:21 Topics: Adenocarcinoma; Cell Count; Cell Division; Colonic Neoplasms; Daunorubicin; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Humans; Intracellular Membranes; Kinetics; Tumor Cells, Cultured	1989
Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial. Cancer treatment reports, 1987, Volume: 71, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Male; Menogaril; Middle Aged; Nogalamycin; Rectal Neoplasms	1987
Cellular pharmacology of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and structural analogues in human colon carcinoma HT-29 cells in vitro. Cancer research, 1987, Aug-01, Volume: 47, Issue:15 Topics: Adenocarcinoma; Bacterial Proteins; Biological Transport; Cell Line; Cell Nucleus; Colonic Neoplasms; Daunorubicin; DNA Replication; Doxorubicin; Escherichia coli; Humans; RNA Polymerase I; Structure-Activity Relationship; Transcription, Genetic; Tumor Stem Cell Assay	1987
Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates. British journal of cancer, 1987, Volume: 56, Issue:6 Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Daunorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Methotrexate; Rectal Neoplasms; Tumor Cells, Cultured	1987
Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin. British journal of cancer, 1986, Volume: 54, Issue:3 Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line; Cell Survival; Colonic Neoplasms; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Humans	1986
Effects of 3'-(4-morpholinyl)-3'-deaminodaunorubicin,3'- (4-methoxy-1-piperidinyl)-3'-deaminodaunorubicin and daunorubicin on nuclear and polysomal RNA synthesis in human colon carcinoma cells in vitro. Cancer letters, 1986, Volume: 33, Issue:2 Topics: Antineoplastic Agents; Carcinoma; Cell Line; Cell Nucleus; Colonic Neoplasms; Daunorubicin; Humans; Polyribosomes; RNA, Neoplasm	1986
Phase II study of daunorubicin in previously untreated patients with advanced colorectal carcinoma. Medical and pediatric oncology, 1985, Volume: 13, Issue:1 Topics: Adenocarcinoma; Aged; Colonic Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Male; Middle Aged; Rectal Neoplasms; Time Factors	1985